Diagnosing BRAF mutations typically involves molecular genetic testing. Techniques such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and allele-specific assays are employed to detect specific mutations in the BRAF gene. These diagnostic tests are crucial for tailoring appropriate therapeutic strategies for cancer patients.
